000888033 000__ 01720cam\a2200397\a\4500
000888033 001__ 888033
000888033 005__ 20210515172900.0
000888033 006__ m\\\\\o\\d\\\\\\\\
000888033 007__ cr\cn\nnnunnun
000888033 008__ 120709s2013\\\\enka\\\\ob\\\\001\0\eng\d
000888033 010__ $$z  2012027613
000888033 020__ $$z9781107008809 
000888033 020__ $$z9781107401358 
000888033 020__ $$z9781107306349 $$q(electronic book)
000888033 035__ $$a(MiAaPQ)EBC1113048
000888033 035__ $$a(Au-PeEL)EBL1113048
000888033 035__ $$a(CaPaEBR)ebr10649562
000888033 035__ $$a(CaONFJC)MIL432144
000888033 035__ $$a(OCoLC)827210355
000888033 040__ $$aMiAaPQ$$cMiAaPQ$$dMiAaPQ
000888033 050_4 $$aQH438.4.S73$$bS56 2013
000888033 08204 $$a610.72/4$$223
000888033 1001_ $$aSimon, Richard M.,$$d1943-
000888033 24510 $$aGenomic clinical trials and predictive medicine$$h[electronic resource] /$$cRichard M. Simon.
000888033 260__ $$aCambridge :$$bCambridge University Press,$$c2013.
000888033 300__ $$axiii, 144 p. :$$bill.
000888033 440_0 $$aPractical guides to biostatistics and epidemiology
000888033 504__ $$aIncludes bibliographical references and index.
000888033 5050_ $$aClinical trial basics -- Actionable prognostic biomarkers -- Phase II designs -- Enrichment designs -- Including both test positive and test negative patients -- Adaptive threshold design -- Multiple predictive biomarkers predictive analysis of clinical trials -- Prospective : retrospective design.
000888033 506__ $$aAccess limited to authorized users.
000888033 650_0 $$aGenomics$$xStatistical methods.
000888033 650_0 $$aClinical trials.
000888033 650_0 $$aMedicine, Preventive.
000888033 852__ $$bebk
000888033 85640 $$3ProQuest Ebook Central Academic Complete $$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=1113048$$zOnline Access
000888033 909CO $$ooai:library.usi.edu:888033$$pGLOBAL_SET
000888033 980__ $$aEBOOK
000888033 980__ $$aBIB
000888033 982__ $$aEbook
000888033 983__ $$aOnline